Caloric restriction is associated with preservation of muscle strength in experimental cancer cachexia

被引:15
作者
Levolger, Stef [1 ]
van den Engel, Sandra [1 ]
Ambagtsheer, Gisela [1 ]
IJzermans, Jan N. M. [1 ]
de Bruin, Ron W. F. [1 ]
机构
[1] Erasmus MC Univ Med Ctr, Dept Surg, Rotterdam, Netherlands
来源
AGING-US | 2018年 / 10卷 / 12期
关键词
caloric restriction; cachexia; muscle wasting; cancer; HYDROXY-BETA-METHYLBUTYRATE; DIETARY RESTRICTION; EICOSAPENTAENOIC ACID; WEIGHT-LOSS; MECHANISMS; SARCOPENIA; AGE; SUPPLEMENTATION; CYTOKINES; ARGININE;
D O I
10.18632/aging.101724
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Caloric restriction increases lifespan and healthspan, and limits age-associated muscle wasting. In this study, we investigate the impact of 30% caloric restriction (CR) in a murine cancer cachexia model. Forty CD2F1 mice were allocated as C26 tumor-bearing (TB) + ad libitum food intake (dietary reference intake [DRI]), TB CR, non-TB (NTB) CR, or NTB matched intake (MI). TB groups were inoculated subcutaneously with 0.5x10(6) C26 cells 14 days after initiating CR. Bodyweight, food intake, and grip-strength were recorded periodically. Gastrocnemius (GCM) and tibialis anterior (TA) muscles were resected and weighed 3 weeks after tumor inoculation. mRNA expression of MuRF1, Atrogin-1, myogenin, and MyoD was determined. At tumor inoculation, the mean body weight of TB CR was 88.6% of initial body weight and remained stable until sacrifice. TB DRI showed wasting before sacrifice. TB groups experienced muscle wasting compared with NTB MI. Grip-strength change was less severe in TB CR. Expression of MuRF1, Atrogin-1, and MyoD was similar between TB DRI and both CR groups. Expression of myogenin was increased in CR groups. In conclusion, caloric restriction limits loss of muscle strength but has no impact on muscle mass despite significant loss of body weight in an experimental cancer-associated cachexia model.
引用
收藏
页码:4213 / 4223
页数:11
相关论文
共 60 条
  • [1] Muscle Wasting in Aged, Sarcopenic Rats Is Associated with Enhanced Activity of the Ubiquitin Proteasome Pathway
    Altun, Mikael
    Besche, Henrike C.
    Overkleeft, Herman S.
    Piccirillo, Rosanna
    Edelmann, Mariola J.
    Kessler, Benedikt M.
    Goldberg, Alfred L.
    Ulfhake, Brun
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2010, 285 (51) : 39597 - 39608
  • [2] The pivotal role of cytokines in muscle wasting during cancer
    Argilés, JM
    Busquets, S
    López-Soriano, FJ
    [J]. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2005, 37 (10) : 2036 - 2046
  • [3] Argiles JM, 1997, MED RES REV, V17, P477, DOI 10.1002/(SICI)1098-1128(199709)17:5<477::AID-MED3>3.3.CO
  • [4] 2-Q
  • [5] Anti-inflammatory therapies in cancer cachexia
    Argiles, Josep M.
    Busquets, Silvia
    Lopez-Soriano, Francisco J.
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 2011, 668 : S81 - S86
  • [6] Argiles Josep M, 2009, Curr Opin Support Palliat Care, V3, P263, DOI 10.1097/SPC.0b013e3283311d09
  • [7] Caloric restriction reduces fiber loss and mitochondrial abnormalities in aged rat muscle
    Aspnes, LE
    Lee, CM
    Weindruch, R
    Chung, SS
    Roecker, EB
    Aiken, JM
    [J]. FASEB JOURNAL, 1997, 11 (07) : 573 - 581
  • [8] β-hydroxy-β-methylbutyrate (HMB) attenuates muscle and body weight loss in experimental cancer cachexia
    Aversa, Zaira
    Bonetto, Andrea
    Costelli, Paola
    Minero, Valerio Giacomo
    Penna, Fabio
    Baccino, Francesco Maria
    Lucia, Simone
    Rossi Fanelli, Filippo
    Muscaritoli, Maurizio
    [J]. INTERNATIONAL JOURNAL OF ONCOLOGY, 2011, 38 (03) : 713 - 720
  • [9] Cancer-associated cachexia
    Baracos, Vickie E.
    Martin, Lisa
    Korc, Murray
    Guttridge, Denis C.
    Fearon, Kenneth C. H.
    [J]. NATURE REVIEWS DISEASE PRIMERS, 2018, 4
  • [10] A randomized, double-blind, placebo-controlled trial of a β-hydroxyl β-methyl butyrate, glutamine, and arginine mixture for the treatment of cancer cachexia (RTOG 0122)
    Berk, Lawrence
    James, Jennifer
    Schwartz, Anna
    Hug, Eugen
    Mahadevan, Anand
    Samuels, Michael
    Kachnic, Lisa
    [J]. SUPPORTIVE CARE IN CANCER, 2008, 16 (10) : 1179 - 1188